Bay City Capital News July 21, 2017 Dayton Misfeldt Op-Ed: Orphan Diseases Or Population Health? Policy Choices Drive Venture Capital Investments
Bay City Capital News July 9, 2017 Bay City Capital and GF Xinde Announce Collaboration on Unique Fund
Events July 9, 2017 10th China Biotechnology Industry Conference – the Biomedical and Health Industry Investment and Financing Summit Forum
Bay City Capital News July 6, 2017 David Beier Op-Ed: China Set To Accelerate Life Science Innovation
Bay City Capital News June 16, 2017 David Beier Op-Ed: Reform Prescription Drug Labeling to Benefit Patients and Their Doctors
Bay City Capital News May 1, 2017 David Beier Op-Ed: Understanding Of Cell Biology By Creating A Cell Atlas Requires Collaboration
Portfolio News April 3, 2017 Cydan Development Announces the Acquisition of Its First Rare Disease Spin-out, Vtesse, Inc. by Sucampo Pharmaceuticals, Inc.
Bay City Capital News March 27, 2017 Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Bay City Capital News March 15, 2017 David Beier Op-Ed: The World Is Completely Unprepared for a Global Pandemic
Bay City Capital News March 3, 2017 David Beier Op-Ed: Drug Price Transparency Bill Will Not Lower Rx Costs